参考文献/References:
[1] Julow J, Major T, Emri M, et al. The application of image fusion in stereotactic brachytherapy of brain tumors[J]. Acta Neurechir (Wien), 2000, 142(11):1253-1258.
[2] Selker RG, Shapiro WR, Burger P, et al. The Brain Tumor Cooperative Group NIH Trial 87-01:a randomized comparision of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine[J].Neurosurgery,2000,51(2):343-355.
[3] Laperriere NJ, Leung PM, Mekenzie S, et al. Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma[J]. Int J Radiat Oncol Biol Phys, 1998, 41(15):1005-1011.
[4] Mayr MT, Crocker IR, Butker EK, et al. Results of interstitial brachytherapy for malignant brain tumors[J]. Int J Oncol, 2002, 21(4):817-823.
[5] Liu Z, Yu X, Guo Y, et al. Interstitial brachytherapy using iridium-192 for malignant brain tumors:clinical results[J].Chin Med J (Engl),1999, 112(2):139-142.
[6] Koot RW, Maarouf M, Halshof MC, et al. Brachytherapy:Results of two different therapy strategies for patients with primary glioblastroma multiforme[J]. Cancer, 2000, 88(12):2796-2802.
[7] Patchell RA, Yaes R J, Beach L, et al. A phase I trial of neutron brachytherapy for the treatment of malignant gliomas[J]. Br J Radiol, 1997, 70(839):1162-1168.
[8] Cosgrove GR, Hochberg FH, Zervas NT, et al. Interstitial irradiation of brain tumors, using a miniature radiosurgery device:initial experience[J]. Neurosurgery, 1997, 40(3):518-523.
[9] Gaspar LE, Zamorano LJ, Shamsa F, et al. Permanent 125-iodine implants for recurrent malignant gliomas[J]. Int J Radiat Oncol Biol Phys, 1999, 43(5):977-982.
[10] Patel S, Breneman JC, Warnick RE, et al. Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme[J]. Neurosnrgery, 2000, 46(5):1123-1128.
[11] Kolotas C, Birn G, Baltas D, et al. CT guided interstitial high dose rate brachytherapy for recurrent malignant gliomas[J]. Br J radiol, 1999, 72(860):805-808.
[12] Chuba PJ, Zamarano L, Hamre M, etal. Permanent I-125brain stem implants in children[J]. Childs Nerv Syst, 1998,14(10):570-577.
[13] Barlas O, Bayindir C, Can M. Interstitial irradiation for craniopharyngioma[J]. Acta Neurochir(Wien), 2000, 142(4):389-395.
[14] Bogart JA, Ungureanu C, Shihadeh E, et al. Resection and permanent I-125 brachytherapy without whole brain irradiation for solitary brain metastasis from non-small cell lung carcinoma[J]. J Neurooncol, 1999, 44(1):53-57.
[15] Kreth FW, Faist M, Rossner R, et al. The risk of interstitial radiotherapy of low-grade gliomas[J]. Radiother Oncol,1997,43(3):253-260.
[16] Houston SC, Crocker IR, Brat DJ, et al. Extraneural metastatic glioblastoma after interstitial brachytherapy[J].Int J Radiat Oncol Biol Phys, 2000, 48(3):831-836.
相似文献/References:
[1]田琦,张丽花,蒋宁一.甲状腺癌131I治疗后合并骨髓增生异常综合征一例[J].国际放射医学核医学杂志,2016,40(3):235.[doi:10.3760/cma.j.issn.1673-4114.2016.03.014]
[2]邓大平,卢峰,孙洪强,等.颅脑肿瘤放射治疗时射野外器官吸收剂量体模法测量与分析[J].国际放射医学核医学杂志,2016,40(4):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
Deng Daping,Lu Feng,Sun Hongqiang,et al.Test and analysis of out-of-field organ dose in intracranial tumor radiotherapy using phantom[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
[3]霍小东,王慧星,阎卫亮,等.血管内皮抑制素对125I近距离照射裸鼠肺癌移植瘤的增敏效应研究[J].国际放射医学核医学杂志,2016,40(5):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
Huo Xiaodong,Wang Huixing,Yan Weiliang,et al.Sensitization effect of endostatin for 125I brachytherapy on transplanted tumor in nude mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
[4]徐蓉生,梅艳,赵力威,等.B超引导下术中125I粒子植入治疗晚期胰腺癌的疗效评价[J].国际放射医学核医学杂志,2016,40(6):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
Xu Rongsheng,Mei Yan,Zhao Liwei,et al.Evaluation of 125I particle implantation in the treatment of patients with advanced pancreatic neoplasms using B ultrasound-guided surgery[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
[5]张丽花,蒋宁一.131I治疗Graves甲亢合并肝功能损害或血细胞减少的优势与风险[J].国际放射医学核医学杂志,2015,39(6):483.[doi:10.3760/cma.j.issn.1673-4114.2015.06.010]
Zhang Lihua,Jiang Ningyi.The advantage and risk of 131I treatment in hyperthyroidism combined with liver injury or blood cell reduction[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):483.[doi:10.3760/cma.j.issn.1673-4114.2015.06.010]
[6]杨宝军.131I治疗甲亢合并特发性血小板减少性紫癜一例[J].国际放射医学核医学杂志,2015,39(6):511.[doi:10.3760/cma.j.issn.1673-4114.2015.06.017]
[7]赵腾,梁军,林岩松.131I治疗前刺激性Tg在分化型甲状腺癌风险评估及治疗决策中的意义[J].国际放射医学核医学杂志,2015,39(1):61.[doi:10.3760/cma.j.issn.1673-4114.2015.01.013]
Zhao Teng,Liang Jun,Lin Yansong.The role of preablative stimulated thyroglobulin in guiding risk estimation and therapeutic decisions of differentiated thyroid carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):61.[doi:10.3760/cma.j.issn.1673-4114.2015.01.013]
[8]杜芳芳,郭阳,姜炜.脑转移瘤的放射治疗进展[J].国际放射医学核医学杂志,2015,39(4):328.[doi:10.3760/cma.j.issn.1673-4114.2015.04.012]
Du Fangfang,Guo Yang,Jiang Wei.Advances in radiotherapy of brain metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):328.[doi:10.3760/cma.j.issn.1673-4114.2015.04.012]
[9]侯朝华,霍彬,宋杨.组织间近距离放射性粒子植入治疗肿瘤的进展[J].国际放射医学核医学杂志,2015,39(4):348.[doi:10.3760/cma.j.issn.1673-4114.2015.04.016]
Hou Zhaohua,HuoBin,SongYang.Organizational close radioactive seed implantation therapy in treating tumor progression[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):348.[doi:10.3760/cma.j.issn.1673-4114.2015.04.016]
[10]俞秀华,黄炜坤,林玉梅.131I治疗Graves病合并肝损害的临床观察[J].国际放射医学核医学杂志,2014,38(2):90.[doi:10.3760/cma.j.issn.1673-4114.2014.02.005]
Yu Xiuhua,Huang Weikun,Lin Yumei.Clinical observation of 131I therapy in Graves disease patients with hepatic dysfunction[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):90.[doi:10.3760/cma.j.issn.1673-4114.2014.02.005]